|
|
 |
|
Viewing report
|
|
|
|
Comparative Analysis of Marketed Drugs in Major Indications - Patent Cliff to Set Off Intense Price Competition in High Volume Markets
GBI Research, Aug 2011, Pages: 195
“Comparative Analysis of Marketed Drugs in Major Indications - Patent Cliff to Set Off Intense Price Competition in High Volume Markets” provides insights regarding the comparative analysis of marketed drugs based on safety, efficacy, cost of therapy and total sales revenue. The report also delves deep into the descriptions of every marketed drug, discussing their safety, efficacy, cost of therapy and clinical studies.
The in-depth analysis of the report is based on propriety databases, primary and secondary research and in-house analysis by a team of experts.
This analysis showed that the marketed drugs had to score highly in terms of safety and efficacy to ensure maximum usage. Patents assisted some of the marketed drugs in generating sales revenue devoid of competition, with some seeking patent extensions as well to ensure additional returns. However, patent expiries have resulted in a decline in the cost of therapy and revenue for some of the marketed drugs.
Scope
- Major indications with sizeable market share and growth.
- Comparative analysis of major marketed drugs in each of the major indications, in terms of safety, efficacy, cost of therapy and total sales revenue of the drugs.
- Detailed description of the drugs, including parameters such as safety, efficacy, cost of therapy and clinical studies.
Reasons to buy
The report will assist business development and help marketing executives to market products and strategize new product launches, by allowing them to -
- Differentiate their products from competitors in terms of safety, efficacy and cost of therapy.
- Invest in research to achieve novelty in treatment with an acceptable safety and efficacy profile; and obtain patents for ensuring monopoly business.
- Exploit licensing and acquisition opportunities by identifying products that might meet their expected returns.
- Focus on the addition of new indications to the existing ones, and different dosage forms for patient compliance.
- Develop key strategic initiatives by studying the key strategies of top competitors.
- Build effective strategies to market their products.
- Develop market-entry and market-expansion strategies by identifying the indications poised for strong growth.
|
|
|
|
